Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5601.

https://doi.org/10.1182/blood-2025-5601

Published: 2025

Journal Articles

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7354.

https://doi.org/10.1182/blood-2025-7354

Published: 2025

Journal Articles

Ruxolitinib for refractory immune effector cell enterocolitis following ciltacabtagene autoleucel CAR T-cell therapy for multiple myeloma

Blood (2025) 146 (Supplement 1): 2392.

https://doi.org/10.1182/blood-2025-2392

Published: 2025

Journal Articles

Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms

Blood (2025) 146 (Supplement 1): 2586.

https://doi.org/10.1182/blood-2025-2586

Published: 2025

Journal Articles

Novel BCR::ABL1 fusion alongside T315I reveals mechanism for dual ponatinib/asciminib resistance and proves sensitive to addition of axitinib

Valentina Nardi, Mohammad Azam, Joshua Schwieterman, Sekhu Ansari, Meenu Kesarwani, George Daley, Zachary Kincaid

Blood (2025) 146 (Supplement 1): 1501.

https://doi.org/10.1182/blood-2025-1501

Published: 2025

Journal Articles

Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma

Makoto Iwasaki, Caroline MacVicar, Anna B Rider, Aliyah R. Sohani, Valentina Nardi, Josie G Ford, Kusha Chopra, Jeffrey A. Barnes, Salvia Jain

Blood (2024) 144 (Supplement 1): 1370.

https://doi.org/10.1182/blood-2024-208061

Published: 2024

Journal Articles

TRK Protein Expression in TP53 Altered Acute Erythroid Leukemia

Rupa Narayan, Ronan T. Swords, Philip C. Amrein, Andrew M. Brunner, Gabriela S. Hobbs, Hanno Hock, Michelle Hyunju Lee, Timothy Aaron Graubert, Amir T. Fathi, Robert P Hasserjian, Valentina Nardi

Blood (2024) 144 (Supplement 1): 6154.

https://doi.org/10.1182/blood-2024-211201

Published: 2024

Journal Articles

The Clinical Impact of Isolated Trisomy 15 in Myelodysplastic Syndrome Is Governed By Its Clonality

Scott Ryall, Harrison K. Tsai, Valentina Nardi, Jon C. Aster, Robert P Hasserjian, Paola Dal Cin

Blood (2024) 144 (Supplement 1): 6745.

https://doi.org/10.1182/blood-2024-207766

Published: 2024

Journal Articles

Hi-C Allows Genome-Wide Characterization of Enhancer-Driven Oncogene Rearrangements in Formalin-Fixed Lymphoid Cancer Biopsies

Jamin Wu, Alec Chu, Jang Cho, Misha Movahed-Ezazi, Kristyn Galbraith, Chanel Schroff, Yiying Yang, Jon-Matthew Belton, Valentina Nardi, Abner Louissaint, Dennis Shasha, Tatyana Gindin, Minji Kim, Marcin P Cieslik, Anthony Schmitt, Matija Snuderl, Russell J. H. Ryan

Blood (2024) 144 (Supplement 1): 4973.

https://doi.org/10.1182/blood-2024-201614

Published: 2024

Journal Articles

A Novel BCR::ABL1 Rearrangement Harboring the Gatekeeper Mutation Drives Hyper-Kinase Activity Conferring Resistance to Ponatinib and Asciminib Combination Therapy

Valentina Nardi, Joshua Schwieterman, Zachary Kincaid, Andrew M. Brunner, Maria Reyes, Gabriel K. Griffin, Sekhu Ansari, Mohammad Azam

Blood (2024) 144 (Supplement 1): 4541.

https://doi.org/10.1182/blood-2024-211279

Published: 2024

Journal Articles

Impact of Ultra Rapid Molecular Profiling on Treatment Delays and Healthcare Utilization of Patients Hospitalized for Acute Leukemia

Tejaswini Dhawale, Valentina Nardi, Charlotte Wang, Adam Bard, Natalia Essigmann, Daniel Leonard, Timothy Aaron Graubert, Amir T. Fathi

Blood (2024) 144 (Supplement 1): 5058.

https://doi.org/10.1182/blood-2024-208059

Published: 2024

Journal Articles

Clonal Hematopoiesis of Indeterminate Potential Does Not Impact Overall Survival in Multiple Myeloma

Farah Rexha, Joshua Gustine, Ryan Han, Rie Nakamoto-Matsubara, Cristina Panaroni, Rajib Shome, Valentina Nardi, Andrew R. Branagan, Diana Cirstea, Andrew J. Yee, Noopur Raje

Blood (2024) 144 (Supplement 1): 3339.

https://doi.org/10.1182/blood-2024-211622

Published: 2024

Journal Articles

Clinical Features and Preliminary Investigation of PPM1D-Mutated Myeloproliferative Neoplasms

Hatem A. Ellaithy, Valentina Nardi, Harrison K. Tsai, Carmen Da Silva, Peter G. Miller, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 4525.

https://doi.org/10.1182/blood-2024-207678

Published: 2024

Journal Articles

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37 + lymphoid malignancies

Blood (2024) 144 (11): 1153–1167.

https://doi.org/10.1182/blood.2024024104

Published: 2024

Includes: Supplemental data

Journal Articles

Low-frequency inherited complement receptor variants are associated with purpura fulminans

Blood (2024) 143 (11): 1032–1044.

https://doi.org/10.1182/blood.2023021231

Published: 2024

Includes: Supplemental data

Journal Articles

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Blood (2022) 140 (16): 1822–1826.

https://doi.org/10.1182/blood.2022015443

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Blood (2021) 138 (23): 2435–2440.

https://doi.org/10.1182/blood.2021012536

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rie Nakamoto-Matsubara, Valentina Nardi, Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, Rakesh Verma, Andrew J. Yee, Andrew R. Branagan, Elizabeth O'Donnell, Noopur S. Raje

Blood (2021) 138 (Supplement 1): 398.

https://doi.org/10.1182/blood-2021-152784

Published: 2021

Journal Articles

Rare Inherited Defects of the Complement System in Purpura Fulminans

Pavan Bendapudi, MD, Justine Ryu, MD, Onuralp Soylemez, Betty Rouaisnel, Meaghan Colling, MD, Bryce Pasko, Alissa Robbins, Michael Bouzinier, Lindsay Tomczak, Sanjay Ram, Agnes Toth-Petroczy, Joel Krier, Elizabeth Fieg, Walter Dzik, MD, James Hudspeth, MD, Olga Pozdnyakova, MD PhD, Valentina Nardi, MD, Richard Maas, Julie-Aurore Losman, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138729

Published: 2020

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Ruxolitinib for refractory immune effector cell enterocolitis following ciltacabtagene autoleucel CAR T-cell therapy for multiple myeloma

Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms

Novel BCR::ABL1 fusion alongside T315I reveals mechanism for dual ponatinib/asciminib resistance and proves sensitive to addition of axitinib

Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma

TRK Protein Expression in TP53 Altered Acute Erythroid Leukemia

The Clinical Impact of Isolated Trisomy 15 in Myelodysplastic Syndrome Is Governed By Its Clonality

Hi-C Allows Genome-Wide Characterization of Enhancer-Driven Oncogene Rearrangements in Formalin-Fixed Lymphoid Cancer Biopsies

A Novel BCR::ABL1 Rearrangement Harboring the Gatekeeper Mutation Drives Hyper-Kinase Activity Conferring Resistance to Ponatinib and Asciminib Combination Therapy

Impact of Ultra Rapid Molecular Profiling on Treatment Delays and Healthcare Utilization of Patients Hospitalized for Acute Leukemia

Clonal Hematopoiesis of Indeterminate Potential Does Not Impact Overall Survival in Multiple Myeloma

Clinical Features and Preliminary Investigation of PPM1D-Mutated Myeloproliferative Neoplasms

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37 + lymphoid malignancies

Low-frequency inherited complement receptor variants are associated with purpura fulminans

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rare Inherited Defects of the Complement System in Purpura Fulminans

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only